BRACKETING AND MATRIXING FUNDAMENTAL PRINCIPLES AND CONCEPTS TO REDUCE STABILITY TESTING
June 12, 2019 | (10:30 AM)
USA (United States of America)
Stability is defined as a critical quality attribute (CQA) in the drug development process, and the cost of stability program is quite significant. ICH Guideline allows to reduce stability testing for stable drug products. Q1D provides details on how these strategies can be applied and different types of reduced testing that might be used. This live training webinar will discuss Q1D Matrixing to apply to Stability Studies, explore the fundamental principles of bracketing and matrixing. It will also show various strategies that reduced testing can be used to obtain stability data, and key factors to minimize the risk of reduce testing.